R-MDMA

R-enantiomer of MDMA (3,4-methylenedioxymethamphetamine)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-MDMA, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants [Phase 1]